Using Real-World Evidence to Increase Patient Diversity in Rare Disease Early Development Trials
Time: 12:00 pm
day: Conference Day Two Track B
Details:
- Racial and ethnic minority populations have historically been underrepresented in rare disease early phase trials
- Reducing barriers to clinical trial diversity is essential for health equity
- Incorporation of real-world evidence into trial planning has the potential to increase recruitment and enrolment of diverse patient populations
